News tagged with gleason score
More aggressive treatment not necessary for men with a family history of prostate cancer
Approximately 10-20 percent of prostate cancer patients have a family history of the disease. There are three major factors that are used to evaluate the extent and aggressiveness of prostate cancer, help make treatment decisions, ...
Oct 05, 2011 |
not rated yet |
0
New tool helps identify prostate cancer patients with highest risk of death
After a prostate cancer patient receives radiation treatment, his doctor carefully monitors the amount of prostate-specific antigen, or PSA, in his blood. An increase in PSA, called biochemical failure, is the first detectable ...
Oct 05, 2011 |
5 / 5 (2) |
0
Predicting the return of prostate cancer: New study betters the odds of success
Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.
Jul 02, 2009 |
not rated yet |
1
Search results for gleason score
Investigational urine test can predict high-risk prostate cancer in men who chose 'watchful waiting'
Initial results of a multicenter study coordinated by researchers at Fred Hutchinson Cancer Research Center indicates that two investigational urine-based biomarkers are associated with prostate cancers that are likely to ...
Feb 02, 2012 |
5 / 5 (1) |
0
Study finds prostate size may help predict cancer severity
(Medical Xpress) -- The size of a man’s prostate gland may help predict the severity of cancer, with a smaller prostate being more likely to harbor serious disease. This finding by a group of Vanderbilt-Ingram Cancer ...
Jan 31, 2012 |
not rated yet |
0
Opting to track, not treat, early prostate cancer
(AP) -- John Shoemaker visited six doctors in his quest to find the best treatment for his early stage prostate cancer - and only the last one offered what made the most sense to the California man: Keep ...
Dec 19, 2011 |
5 / 5 (1) |
0
Panel endorses active monitoring and delay of treatment for low-risk prostate cancer
An independent panel convened this week by the National Institutes of Health has concluded that many men with localized, low-risk prostate cancer should be closely monitored, permitting treatment to be delayed until warranted ...
Dec 08, 2011 |
not rated yet |
0
Fox Chase Gleason scores better predict prostate cancer's recurrence after radiation
–In a new study led by Fox Chase Cancer Center radiation oncologist Natasha Townsend, M.D., researchers have found that Gleason scores determined by pathologists at Fox Chase Cancer Center more accurately predict the ...
Oct 05, 2011 |
5 / 5 (1) |
0
Inflammation marker may guide prognosis for prostate cancer
(Medical Xpress) -- Current methods of prostate cancer detection, like the prostate-specific antigen (PSA) test, often fail to identify which cancers will prove fatal and which cancers will remain benign until a patient dies ...
Sep 28, 2011 |
4.7 / 5 (3) |
0
Five inherited genetic variants linked to the most lethal prostate cancers
An international team of researchers led by Fred Hutchinson Cancer Research Center has identified five inherited genetic variants that are strongly associated with aggressive, lethal prostate cancer. The discovery ultimately ...
Aug 16, 2011 |
5 / 5 (2) |
2
|
Urine test shows prostate cancer risk
A new urine test can help aid early detection of and treatment decisions about prostate cancer, a study from the University of Michigan Comprehensive Cancer Center and the Michigan Center for Translational Pathology finds.
Aug 03, 2011 |
5 / 5 (1) |
0
Short-term hormone therapy plus radiation therapy increases survival for men with early-stage prostate cancer
Short-term hormone therapy (androgen deprivation therapy: ADT) given in combination with radiation therapy for men with early-stage prostate cancer increases their chance of living longer and not dying from the disease, compared ...
Jul 13, 2011 |
5 / 5 (1) |
0
Study suggests another look at testosterone-prostate cancer link
The long-standing prohibition against testosterone therapy in men with untreated or low-risk prostate cancer merits reevaluation, according to a new study published in The Journal of Urology.
Apr 19, 2011 |
not rated yet |
0
List of search results for gleason score
